Vaccine to treat deadliest brain cancer found to nearly DOUBLE survival rate

A vaccine to slow the progression of the deadliest form of brain cancer has shown promise in early clinical trials by extending the average survival time from 15 to 26 months.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news